The mechanism likely involves the convergence of multiple prothrombotic stimuli, including cytokine release en masse, widespread endothelial activation with TF upregulation, and release of procoagulant microparticles from activated T-cells and dying tumor cells. The gene discussed is TF; the disease is neoplasm.